A new study published in Phytotherapy Research, found that a patented extract of Andrographis paniculata (ParActin by HP Ingredients; Brandenton, FL) improved symptoms of joint discomfort in the knee.
Photo © Shutterstock.com/Sebastian Kaulitzki
A new study published in Phytotherapy Research, found that a patented extract of Andrographis paniculata (ParActin by HP Ingredients; Brandenton, FL) improved symptoms of joint discomfort in the knee. In the double-blind, randomized, placebo-controlled study, 103 adults with mild to moderate osteoarthritis in the knee were given either, 300 mg of the herb, 600 mg of the herb, or placebo daily for 84 days.
Researchers utilized the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) to assess pain in the subjects. Pain scores began showing a significant progressive reduction in the Andrographis groups starting at 28 days, compared to placebo, which did not show a significant reduction. WOMAC scores for joint stiffness also significantly decrease in the Andrographis group, starting at 28 days, compared to placebo. Scores for physical function also improved for subjects taking the herb, at days 56 and 84, compared to placebo. Both dosages of 300 mg and 600 mg were found to be efficacious, though one was not significantly better than the other.
1. Hancke JL et al. “A doubleâblind, randomized, placeboâcontrolled study to assess the efficacy of Andrographis paniculata standardized extract (ParActin®) on pain reduction in subjects with knee osteoarthritis.” Phytotheraphy Research (2019): 1-11
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.